Literature DB >> 15580550

Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease.

J Eric Ahlskog1.   

Abstract

Oxidative stress is well documented in Parkinson's disease (PD) and has been attributed to dopamine oxidative metabolism. However, evidence of oxidative stress is found in a variety of neurodegenerative disorders, suggesting that more general factors are responsible or that cytodestructive processes secondarily generate oxyradical products. Increasing evidence points away from dopamine metabolism as an important contributor to PD neurodegeneration. Predictions from the dopamine oxidative stress hypothesis of PD reveal multiple inconsistencies. Although the clinical and therapeutic importance of the nigrostriatal dopaminergic system is undeniable, PD neuropathology is much more widespread. 2004 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15580550     DOI: 10.1002/mds.20362

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  20 in total

Review 1.  Cheaper, simpler, and better: tips for treating seniors with Parkinson disease.

Authors:  J Eric Ahlskog
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

Review 2.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 3.  Oxidative and inflammatory pathways in Parkinson's disease.

Authors:  Rebecca L Miller; Marilyn James-Kracke; Grace Y Sun; Albert Y Sun
Journal:  Neurochem Res       Date:  2008-03-25       Impact factor: 3.996

4.  Seniors with Parkinson's disease: initial medical treatment.

Authors:  J Eric Ahlskog
Journal:  J Clin Neurol       Date:  2010-12-31       Impact factor: 3.077

Review 5.  Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?

Authors:  J Eric Ahlskog; Ryan J Uitti
Journal:  Neurology       Date:  2010-04-06       Impact factor: 9.910

6.  The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.

Authors:  Matthew J Benskey; Fredric P Manfredsson; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2014-11-20       Impact factor: 4.294

Review 7.  The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential.

Authors:  K Ray Chaudhuri; L Yates; P Martinez-Martin
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

8.  TRPM2 Promotes Neurotoxin MPP+/MPTP-Induced Cell Death.

Authors:  Yuyang Sun; Pramod Sukumaran; Senthil Selvaraj; Nicholas I Cilz; Anne Schaar; Saobo Lei; Brij B Singh
Journal:  Mol Neurobiol       Date:  2016-12-12       Impact factor: 5.590

9.  Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein.

Authors:  Matthew Benskey; Ki Yong Lee; Kevin Parikh; Keith J Lookingland; John L Goudreau
Journal:  Neurotoxicology       Date:  2013-05-01       Impact factor: 4.294

10.  Association between Anemia and Risk of Parkinson Disease.

Authors:  Yao-Chin Wang; Abel Po-Hao Huang; Sheng-Po Yuan; Chu-Ya Huang; Chieh-Chen Wu; Tahmina Nasrin Poly; Suleman Atique; Woon-Man Kung
Journal:  Behav Neurol       Date:  2021-07-07       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.